C12N 2720/12034
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2720/12034 (Use of virus or viral component as vaccine) appears on 27 US grants and 34 published applications in this corpus.
Search patents in C12N- Granted patents
- 27
- Published applications
- 34
- Assignees
- 24
- Inventors
- 78
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 1 | 2 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 1 | 2 |
| 2009 | 0 | 0 |
| 2010 | 1 | 2 |
| 2011 | 0 | 2 |
| 2012 | 1 | 0 |
| 2013 | 0 | 3 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 3 | 1 |
| 2017 | 0 | 2 |
| 2018 | 0 | 3 |
| 2019 | 2 | 3 |
| 2020 | 3 | 2 |
| 2021 | 1 | 1 |
| 2022 | 0 | 4 |
| 2023 | 4 | 2 |
| 2024 | 2 | 2 |
| 2025 | 0 | 0 |
| 2026 | 2 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Attenuated avian reovirus strains 94826 C140 and 96139 C14014 Apr 2026US 12,599,659 B2University of Georgia Research Foundation, Inc.
- Method for vaccinating avians against reovirus24 Feb 2026US 12,558,414 B2Biomune Company
- Method for producing artificial recombinant rotavirus8 Oct 2024US 12,109,262 B2Osaka University
- Mammal-specific growth-defective arbovirus24 Sep 2024US 12,098,393 B2TenGen Biomedical Company
- Human rotavirus G9P[6] strain and use as a vaccine19 Sep 2023US 11,759,513 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Attenuated reovirus-based vaccine composition and use thereof16 May 2024US 2024/0156944 A1Virocure, Inc.
- Optimized polypeptide for a subunit vaccine against avian reovirus15 Feb 2024US 2024/0050556 A1Gavish-Galilee Bio Applications Ltd.
- Multivalent vaccines against turkey arthritis reovirus5 Oct 2023US 2023/0310574 A1
- Attenuated avian reovirus strains 94826 c140 and 97139 c1405 Jan 2023US 2023/0000972 A1University of Georgia Research Foundation, Inc.
- Method for producing artificial recombinant rotavirus3 Nov 2022US 2022/0347288 A1Osaka University
Most cited
By later US patents
- Avian proventriculitis vaccine12US 4,559,229 AThe Research Foundation · 1985
- Antigenic class of avian reoviruses11US 6,951,650 B1Akzo Nobel N. V. · 2005
- Ovo immunization of avian embryos with oil-emulsion vaccines7US 5,750,101 AThe United States of America as represented by the Secretary of Agriculture · 1998
- Process for the preparation of inducers of non-specific immunity and product produced5US 5,094,850 ABayer Aktiengesellschaft · 1992
- Vaccines4US 4,515,777 AGist-Brocades N. V. · 1985